当前位置: X-MOL 学术J. Pediat. Inf. Dis. Soc. › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Weighing the Risks of Perimyocarditis With the Benefits of SARS-CoV-2 mRNA Vaccination in Adolescents
Journal of the Pediatric Infectious Diseases Society ( IF 2.5 ) Pub Date : 2021-07-16 , DOI: 10.1093/jpids/piab061
Ravi Jhaveri 1, 2 , Felice C Adler-Shohet 3, 4 , Christopher C Blyth 5 , Kathleen Chiotos 6 , Jeffrey S Gerber 7 , Michael Green 8 , Larry Kociolek 1, 2 , Rachel Martin-Blais 9 , Debra Palazzi 10 , Andi L Shane 11 , Jennifer E Schuster 12 , Stanford T Shulman 1, 2 , Gregory A Storch 13 , Geoffrey A Weinberg 14 , Theoklis Zaoutis 7
Affiliation  

The overwhelming burden of the COVID-19 pandemic persists in many parts of the world [1]. In the United States, efforts to vaccinate adults, and more recently adolescents, against SARS-CoV-2 have brought hope for a return to pre-pandemic work and school life. With widespread vaccination have come rare reports of perimyocarditis, predominantly occurring in adolescents and young adults [2–4]. Understandably, these reports, identified through well-established systems designed to detect rare vaccine side effects, have raised concerns and are being carefully assessed.

中文翻译:

用 SARS-CoV-2 mRNA 疫苗在青少年中的益处权衡心肌周围炎的风险

COVID-19 大流行的巨大负担在世界许多地方持续存在 [1]。在美国,为成年人和最近的青少年接种 SARS-CoV-2 疫苗的努力为重返大流行前的工作和学校生活带来了希望。随着广泛接种疫苗,出现了罕见的心肌周围炎报告,主要发生在青少年和年轻成人中 [2-4]。可以理解的是,这些报告是通过旨在检测罕见疫苗副作用的完善系统确定的,引起了人们的关注并正在仔细评估。
更新日期:2021-07-16
down
wechat
bug